◆ 会议时间：2024年12月12-15日
◆ 会议地点：马来西亚 吉隆坡
◆ 会议简介：
2024年亚太过敏、哮喘和临床免疫学协会(APAAACI)国际大会(年会)将于2024年12月12-15日在马来西亚吉隆坡举行，会议由APAAACI与马来西亚过敏和免疫学学会(MSAI)联合举办。
亚太过敏、哮喘和临床免疫学协会(APAAACI)成立于1989年，原名为亚太过敏与临床免疫学协会（APAACI）,2007年更为现名APAAACI。APAAACI的主要目标是鼓励和支持该地区过敏、哮喘和临床免疫学学科的发展，特别是那些还没有专业学会组织的国家。APAAACI由代表各自地理区域内过敏学专业人士宣的学会构成，包括：澳大利亚临床免疫和过敏学会；韩国哮喘、过敏和临床免疫学学会；日本变态反应学会；菲律宾过敏、哮喘和免疫学学会；泰国过敏、哮喘和免疫学协会；新加坡过敏与临床免疫学会；、印度过敏、哮喘和应用免疫学学会；印尼过敏和免疫学学会；中国变态反应学会；马来西亚过敏和免疫学学会；台湾过敏哮喘和临床免疫学学会；孟加拉国过敏和免疫学学会；蒙古国变态反应学会；斯里兰卡过敏和免疫学学会；台湾过敏哮喘和临床免疫学学会；香港变态反应协会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.
APAAAC 2024 - Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI) Congress
Dates:
23-26 October 2023
Venue:
Kuala Lumpur, Malaysia
Theme:
New Paradigms in Allergy, Asthma and Immunology: From Augmented Intelligence, Exposomes to Precision Medicine
Organized By:
Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI)
Malaysian Society of Allergy and Immunology (MSAI)
摘要征文投稿：
Submission Deadline: 31 July 2024
点此提交摘要>>>Submit Abstract>>>
All abstracts must be submitted in English using the online submission form available on the link above.
NOTE: Abstracts submitted by email, fax or post will NOT be accepted. The Congress organizers will not accept responsibility for any abstracts that have not been properly submitted according to the instructions.
Language
All abstracts are to be written in English. The Scientific Committee reserves the right to edit abstracts where the English structure makes comprehension difficult.
Correspondence
Corresponding authors must provide the organizers with their full mailing address, office hours phone number, fax number and email address. Author and co-author information must be provided including the first and last names of all authors, their department, institution / hospital, city, state if applicable and country. Abstracts must contain original scientific data collected by the author(s). All abstracts will be reviewed by the Scientific Committee. The Scientific Committee reserves the right to determine whether a submission is accepted as a one of the categories of submission and its decision is final. The Scientific Committee reserves the right to edit abstracts for grammar and clarity. The Abstract may be scheduled for presentation on any day from 12-15 December 2024. For any queries, please contact the secretariat – apaaaci2024@wearemci.com
Structure
- The title must be brief, concise, and in CAPITAL LETTERS.
- Abstract title limit: 15 words.
- Authors: Please enter your name and your colleagues’ names as you wish them to appear in the Final Program.
- The Abstract text should have a maximum of 500 words
- The Scientific Committee reserves the rights to reject any submission.
- Do not include references in the abstract.
- Do not include keywords in the abstract.
- Abbreviations should be spelled out, in parenthesis, in its first use in the abstract.
The abstract content should include:
- Purpose of the study
- Materials and methods used.
- Results
- Conclusion
- Authors and their affiliations
Dear Friends and Colleagues,
Allergic diseases and asthma are rapidly growing health problems worldwide with a marked socio-economic impact. Alongside rapid environmental and lifestyle changes, the fast-evolving economies in Asia-Pacific face an increasing burden of allergic diseases. Advances in science, epidemiology, epigenetics, innovation, and technology continually challenge countries in the post-pandemic world. The Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI) together with the Malaysian Society of Allergy and Immunology (MSAI) will host the APAAACI 2024 Congress from the 12th – 15th December 2024 in Kuala Lumpur, Malaysia.
The scientific program is being developed as a well-woven combination of cutting edge advances and practical clinical aspects in allergy, asthma, and clinical immunology, addressing the needs of both clinicians and researchers across specialties working in this space. With key international, regional, and national opinion leaders, this will be a truly unique platform for leaders, colleagues, and junior members to share knowledge, network, and interact for the best scientific exchange and future collaborations. We hope the Congress will provide a unique platform as a knowledge base in the treatment and prevention of Allergies, Asthma, and Immunologic Disease.
On behalf of the APAAACI and MSAI, we welcome our industry partners to be part of this Congress. Your support will play an integral part in making the Congress a scientifically rewarding event for all those who participate. Together we can make a difference to the community at large.
Let’s make the APAAACI 2024 Congress a success! We look forward to your active participation!
| |
|
|
Prof. Jiu Yao Wang
Congress Chair |
Prof. Ruby Pawankar
Congress Chair |
Prof. Kent Woo Chee Keen
Congress Co-Chair |
注册费：
| Category |
Early Registration (USD)
Until 15 Sep 2024 |
Normal Registration (USD)
16 Sep 2024 – 10 December 2024 |
Onsite Registration (USD)
Post 10 December 2024 |
| International Delegate |
USD 585.00 |
USD 685.00 |
USD 785.00 |
| Local Delegate |
USD 425.00 |
USD 475.00 |
USD 525.00 |
| Low Income Countries** |
USD 370.00 |
USD 425.00 |
USD 475.00 |
| Resident/ Fellow in Training |
USD 320.00 |
USD 370.00 |
USD 425.00 |
| Student/ Allied Health |
USD 265.00 |
USD 315.00 |
USD 370.00 |
| Congress workshop on 12 December 2024 |
Complimentary – Delegate must be registered for the conference. Registration would be on first come first serve basis. |
| Accompanying Person |
USD 200 |
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
